Skip to main content

Table 2 Age in relation to disease-modifying antirheumatic drug treatment within 3 months after disease onset a

From: Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study

Covariates OR 95% CI P-value
Age at disease onsetb 0.403 0.217 to 0.749 <0.01
Female sex 1.002 0.535 to 1.878 0.994
ACPA-positive 1.484 0.812 to 2.712 0.199
ESR (T0), mm/h 1.027 1.009 to 1.045 <0.01
  1. aACPA, Anticyclic citrullinated peptide/protein; CI: Confidence interval; DMARD, Disease-modifying antirheumatic drug; ESR, Erythrocyte sedimentation rate; OR: Odds ratio. bAge at disease onset classified as young-onset rheumatoid arthritis <58 years old and late-onset rheumatoid arthritis ≥58 years old. Data are derived from multiple logistic regression (n = 562).